Immuron (IMRN) Current Assets (2016 - 2025)
Immuron's quarterly Current Assets came in at $99780.0 in Q3 2025, down 32.24% year-on-year from $147263.4 in Q3 2024, and down 98.44% quarter-over-quarter from $6.4 million in Q2 2025.
Immuron has reported Current Assets for 10 years, with the latest figure at $99780.0 in Q3 2025.
- For the quarter ending Q3 2025, Current Assets fell 32.24% year-over-year to $99780.0; the trailing twelve-month figure through Sep 2025 stood at $99780.0 (down 32.24% YoY), and the FY2025 full-year result was $99780.0, down 32.24% from the prior year.
- Current Assets for Q3 2025 stood at $99780.0, down from $6.4 million in the prior quarter.
- The five-year high for Current Assets was $18.8 million in Q4 2021, with the low at $99780.0 in Q3 2025.
- Average Current Assets over 5 years is $7.3 million, with a median of $7.1 million recorded in 2024.
- Year-over-year, Current Assets jumped 6775.75% in 2021 and plunged 99.21% in 2023.
- Tracing IMRN's Current Assets over 5 years: stood at $18.8 million in 2021, then declined by 17.1% to $15.6 million in 2022, then plunged by 99.21% to $123340.8 in 2023, then surged by 6132.72% to $7.7 million in 2024, then sank by 98.7% to $99780.0 in 2025.
- The last three Current Assets figures came in at $99780.0 (Q3 2025), $6.4 million (Q2 2025), and $7.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | 99,780.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 99,780.03 |
| Jun 30, 2025 | 6.41 Mn |
| Dec 31, 2024 | 7.69 Mn |
| Sep 9, 2024 | 147,263.37 |
| Jun 30, 2024 | 9.71 Mn |
| Dec 31, 2023 | 123,340.82 |
| Sep 28, 2023 | 13.38 Mn |
| Aug 30, 2023 | 204,093.37 |
| Jun 30, 2023 | 13.64 Mn |
| Dec 31, 2022 | 15.55 Mn |
| Aug 31, 2022 | 16.46 Mn |
| Jun 30, 2022 | 236,721.52 |
| Dec 31, 2021 | 18.76 Mn |
| Jun 30, 2021 | 257,527.78 |
| Dec 31, 2020 | 272,856.21 |
| Sep 1, 2020 | 4.41 Mn |
| Jun 30, 2020 | 2.89 Mn |
| Dec 31, 2019 | 44,090.41 |
| Jun 30, 2019 | 4.68 Mn |
| Dec 31, 2018 | 7.05 Mn |
| Sep 27, 2018 | 5.16 Mn |
| Aug 30, 2018 | 7.05 Mn |
| Jun 30, 2018 | 5.34 Mn |
| Dec 31, 2017 | 6.44 Mn |
| Sep 28, 2017 | 6.52 Mn |
| Aug 31, 2017 | 8.27 Mn |
| Jun 30, 2017 | 6.21 Mn |
| Dec 31, 2016 | 6.64 Mn |